Belgium (BE)

Motorized spiral enteroscopy: Results of an international multicenter prospective observational clinical study in patients with normal and altered gastrointestinal anatomy (2022) Beyna T, Moreels T, Arvanitakis M, Pioche M, Saurin JC, May A, Knabe M, et al. Journal article Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2) (Rheumatology and Therapy, (2022), 10.1007/s40744-022-00444-x) (2022) Schett G, Loza MJ, Palanichamy A, Fitzgerald O, Ritchlin C, Bay-Jensen AC, Nielsen SH, et al. Journal article, Erratum Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres (2022) Zandee WT, Merola E, Poczkaj K, de Mestier L, Klümpen HJ, Geboes K, de Herder WW, Munir A Journal article Loss-of-function variants in SRRM2 cause a neurodevelopmental disorder (2022) Cuinat S, Nizon M, Isidor B, Stegmann A, van Jaarsveld RH, van Gassen KL, van der Smagt JJ, et al. Journal article Carbamazepine efficacy in a severe electro-clinical presentation of SLC13A5-epilepsy (2022) Santalucia R, Vilain C, Soblet J, De Laet C, Vuckovic A, König J, Aeby A Journal article Kidney Transplantation After Rescue Allocation-the Eurotransplant Experience: A Retrospective Multicenter Outcome Analysis. (2022) Assfalg V, Miller G, Stocker F, Van Meel M, Groenevelt T, Tieken I, Ankerst D, et al. Journal article The first virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic remission in Ulcerative Colitis (2022) Iacucci M, Cannatelli R, Parigi TL, Buda A, Labarile N, Nardone OM, Tontini GE, et al. Conference contribution A new simplified histology artificial intelligence system for accurate assessment of remission in Ulcerative Colitis (2022) Villanacci V, Parigi TL, Del Amor R, Esbri PM, Gui X, Bazarova A, Bhandari P, et al. Conference contribution A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis (2022) Peyrin-Biroulet L, Arkkila P, Armuzzi A, Atreya R, Danese S, Ferrante M, Guardiola J, et al. Conference contribution Efficacy of risankizumab rescue therapy in patients with moderately to severely active Crohn's Disease and inadequate response to risankizumab maintenance therapy (2022) Baert FJ, Atreya R, Kakuta Y, Long M, Roblin X, Neimark E, Song A, et al. Conference contribution